-
Signature
-
/s/ Jonathan Isler, Attorney-in-Fact
-
Stock symbol
-
CMAX
-
Transactions as of
-
Nov 17, 2022
-
Transactions value $
-
$0
-
Form type
-
4
-
Date filed
-
11/21/2022, 06:31 PM
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
CMAX |
Restricted Stock Units |
Award |
$0 |
+12.1K |
|
$0.00 |
12.1K |
Nov 17, 2022 |
Class A Common Stock |
12.1K |
$0.00 |
Through Deerfield Management Company, L.P. |
F1, F2, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Kevin Berg, an employee of Deerfield Management, serves as a director of the Issuer. Jonathan Isler, Attorney-in-Fact: Power of Attorney, which is hereby incorporated by reference to Exhibit 24 to a Form 4 with regard to DA32 Life Science Tech Acquisition Corp. filed with the Securities and Exchange Commission on August 3, 2021 by Deerfield Partners, L.P., Deerfield Mgmt, L.P., Deerfield Management Company, L.P. and James E. Flynn.